𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: A case for subcutaneous administration

✍ Scribed by Debbie M Nathan; John H Iser; Peter R Gibson

Book ID
108951455
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
73 KB
Volume
23
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Efficacy and safety of tacrolimus in ref
Efficacy and safety of tacrolimus in refractory ulcerative colitis and Crohn's disease: A single-center experience
✍ Aaron Benson; Terrence Barrett; Marshall Sparberg; Alan L. Buchman πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 129 KB πŸ‘ 2 views

## Background: The published experience regarding the use of tacrolimus in crohn's disease (cd) and ulcerative colitis (uc) refractory to more commonly used medical therapy has been fairly limited. our objective was to describe our experience with its use in a cohort of patients which, to our knowl

Methotrexate for maintenance of remissio
Methotrexate for maintenance of remission in chronic active Crohn's disease: Long-term single-center experience and meta-analysis of observational studies
✍ Johannes Hausmann; Kai Zabel; Eva Herrmann; Oliver SchrΓΆder πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 344 KB

Background: According to current guidelines methotrexate (MTX) should be considered as a second-line immunomodulator in patients with chronic active Crohn's disease (CD) if purine analogs are not tolerated or there is a lack of efficacy. However, its therapeutic role remains controversial to the pre